NCT00920205 Safety Study of MPC-3100 in Cancer Patients Who Have Failed Other Treatments Status COMPLETED Phase PHASE1
NCT00920140 Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias Status COMPLETED Phase PHASE2
NCT00911261 Oxymorphone Extended Release in Patients With Cancer or Neuropathic Pain Status COMPLETED Phase PHASE3
NCT00911170 PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study Status COMPLETED Phase PHASE3
NCT00907205 A Dose Escalation Study of SF1126, a PI3 Kinase (PI3K) Inhibitor, Given By Intravenous (IV) Infusion in Patients With Solid Tumors Status COMPLETED Phase PHASE1
NCT00907166 A Phase I/II Open-Label Dose-Escalation Clinical Trial of CPI-613 in Combination With Gemcitabine in Cancer Patients Status TERMINATED Phase PHASE1/PHASE2
NCT00906750 A Study of a Live Intranasal Influenza Vaccine in Children With Cancer Status COMPLETED Phase PHASE1
NCT00904579 Cancer Risk in Organ Transplant Recipients and End-Stage Renal Disease Status COMPLETED Phase N/A
NCT00904514 Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial Status TERMINATED Phase N/A
NCT00901264 Microculture Kinetic (MiCK) Apoptosis Test Results With Drug Treatment Results in Cancer Patients Status COMPLETED Phase N/A
NCT00900302 OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer Status COMPLETED Phase N/A
NCT00899496 Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants Status COMPLETED Phase N/A
NCT00891761 A Study of IV Casopitant for the Prevention of Nausea and Vomiting Caused By Cisplatin-Based Highly Emetogenic Chemotherapy Status WITHDRAWN Phase PHASE3
NCT00888810 Efficacy of Topotecan and Lapatinib in Early Recurrent Ovarian or Peritoneal Cancer Status TERMINATED Phase PHASE2
NCT00888316 Iron Overload in Patients Undergoing Donor Stem Cell Transplant Status COMPLETED Phase N/A
NCT00886457 5-aza-2-deoxycytidine With Pegylated Interferon-alfa 2B: A Phase I Study With Molecular Correlates Status TERMINATED Phase PHASE1
NCT00880321 A Phase I Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of GSK2118436 in Subjects With Solid Tumors Status COMPLETED Phase PHASE1
NCT00879775 Efficacy of Caffeine Injection as an Adjuvant to Opioid Therapy in Cancer Pain Status COMPLETED Phase PHASE2